tegafur has been researched along with Hepatitis B, Chronic in 1 studies
Hepatitis B, Chronic: INFLAMMATION of the LIVER in humans caused by HEPATITIS B VIRUS lasting six months or more. It is primarily transmitted by parenteral exposure, such as transfusion of contaminated blood or blood products, but can also be transmitted via sexual or intimate personal contact.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ito, T | 1 |
| Okubo, K | 1 |
| Shiomi, M | 1 |
| Narita, M | 1 |
| Morita, K | 1 |
| Takeuchi, A | 1 |
| Kanazawa, H | 1 |
| Shimizu, J | 1 |
| Takeyama, T | 1 |
| Hashizume, K | 1 |
| Shibahara, H | 1 |
| Nishimura, D | 1 |
| Katada, N | 1 |
| Katano, Y | 1 |
| Goto, H | 1 |
1 other study available for tegafur and Hepatitis B, Chronic
| Article | Year |
|---|---|
[A case of successful treatment of granulocyte colony-stimulating factor producing hepatocellular carcinoma accompanying type B hepatitis with tegafur-uracil].
Topics: Adult; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, H | 2012 |